Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share (Tables)

v3.7.0.1
Net Loss per Share (Tables)
3 Months Ended
Mar. 31, 2017
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following tables set forth the computation of diluted net loss per weighted average number of shares outstanding attributable to Synthetic Biologics and Subsidiaries for the three months ended March 31, 2017 and 2016 (in thousands except share and per share amounts): 
 
 
 
Three months ended March 31, 2017
 
Three months ended March 31, 2016
 
 
 
Net loss
(Numerator)
 
Shares
(Denominator)
 
Per Share
Amount
 
Net Loss
(Numerator)
 
Shares
(Denominator)
 
Per Share
Amount
 
Net loss - Basic
 
$
(2,846)
 
 
117,447,260
 
$
(0.02)
 
$
(10,845)
 
 
90,826,752
 
$
(0.12)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilutive shares related to warrants
 
 
-
 
 
-
 
 
-
 
 
-
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss - Dilutive
 
$
(2,846)
 
 
117,447,260
 
$
(0.02)
 
$
(24,880)
 
 
90,826,752
 
$
(0.12)